Inflation Reduction Act Could Cause Delay in New Oncology Treatments Under Medicare Negotiations
Pharmacy Times
NOVEMBER 3, 2023
In an article by The New England Journal of Medicine, the authors discuss how drug companies could delay the approval of new oncology drugs under the IRA, delaying patient care.
Let's personalize your content